<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00355797</url>
  </required_header>
  <id_info>
    <org_study_id>20060536</org_study_id>
    <nct_id>NCT00355797</nct_id>
  </id_info>
  <brief_title>Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response</brief_title>
  <acronym>CLEAR</acronym>
  <official_title>CLEAR: Cylos Pacemaker Responds With Physiologic Rate Changes During Daily Activities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, prospective, single-blinded, multi-center study involving approximately
      1500 patients at 100 centers. The purpose of this study is to demonstrate the effectiveness
      of Closed Loop Stimulation (CLS) rate adaption technology over both standard rate responsive
      technology (R) and non-rate responsive mode (DDD) during activities of daily living (ADL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients enrolled in the CLEAR study are implanted with a Cylos pacemaker with Closed
      Loop Stimulation (CLS) rate adaption technology. Any legally marketed pacing leads may be
      implanted with the Cylos family of pacemakers.

      Prior to enrollment, patients provide written informed consent and are screened to ensure
      they are eligible to participate in the study. Patients enrolled in the study must have been
      implanted within 45 days prior to enrollment or are being considered for implant. Once
      enrolled and implanted with the Cylos pacemaker, the first 500 patients have 45 days to
      complete an ADL Testing visit. At the Activities of Daily Living (ADL) testing visit, each of
      the first 500 enrolled patients performs a 6-minute walk test, orthostatic test, and sweep
      test in three pacing modes, CLS (DDD-CLS or VVI-CLS), standard rate response (DDDR or VVIR)
      and non-rate responsive mode (DDD or VVI). The order of the pacing modes for testing is
      randomized in a 1:1:1 ratio. The study primarily analyzes the number of ADL repetitions
      performed during the 6-minute walk and sweep tests, pulse pressure during the orthostatic
      test, and secondarily analyzes heart rates during all three tests to compare CLS to both rate
      responsive and non-rate responsive pacing modes.

      For all enrolled patients, the study collects additional data over a 12-month period.
      Patients are randomized and their pacemaker programmed to one of three pacing modes, CLS, R,
      or no-rate response in a 2:1:1 ratio, respectively. The patients are then followed for a
      period of 12 months after the ADL testing (first 500 enrolled patients) or enrollment
      (patients 501 through 1500). The study collects the following secondary measures to compare
      CLS to both rate responsive and non-rate responsive pacing modes: changes in 6-minute walk
      test distance, quality of life, mode reprogramming, atrial fibrillation (AF) burden, cardiac
      symptoms, and New York Heart Association (NYHA) classification.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance of Activities of Daily Living Tests (6-minute Walk and Sweep)</measure>
    <time_frame>within 45 days of enrollment</time_frame>
    <description>Six-minute walk test and sweep test results for subjects completing tests in all three pacing modes and requiring at least 80% pacing during both tests in the CLS and R pacing modes. The mean composite of repetitions (six minute walk plus sweep) are presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse Pressure During Activities of Daily Living Tests (Orthostatic Test)</measure>
    <time_frame>within 45 days of enrollment</time_frame>
    <description>Patients completing the orthostatic test in all three pacing modes and that had at least 80% pacing during the test in the CLS and R pacing modes are included in the analysis. The mean pulse pressure is provided.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Change in Quality of life (QOL) score was determined from baseline to the 12 month follow-up visit. The QOL utilized the physical functioning scale of the SF-36 v2, in which a higher score indicates a better health perception. Best possible score was 57.03 while the worst possible score was 14.94.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode Reprogramming</measure>
    <time_frame>12 months</time_frame>
    <description>Number of subjects with device reprogramming from dual (atrial and ventricular pacing) to single chamber (ventricular pacing only) or from single (ventricular pacing only) to dual chamber (atrial and ventricular pacing) during the 12 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial Fibrillation (AF) Burden</measure>
    <time_frame>12 months</time_frame>
    <description>AF burden was measured at 12 months as the percentage of total atrial beats that are at or above 160 bpm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Symptoms</measure>
    <time_frame>12 months</time_frame>
    <description>Number of subjects exhibiting each cardiac symptom was determined at the 12 month follow-up visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in New York Heart Association (NYHA) Class</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Number of subjects with improved, no change, or worsened NYHA classification at the 12-month visit, as compared to baseline. NYHA classifications (I to IV) are used to assess the various stages of heart failure, with Class I relating to mild heart failure and Class IV relating to severe heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6-minute Walk Test Distance</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Change in number of 10 foot repetitions between baseline and 12-month visit were examined.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1491</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>Closed Loop Stimulation (CLS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacemaker programmed with Closed Loop Stimulation rate adaptive technology for long-term follow-up data collection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Rate Adaptive Technology (R)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term follow-up data collection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-rate adaptive pacing (DDD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacemaker programmed with no rate adaption (DDD mode) for long-term follow-up data collection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Closed Loop Stimulation (CLS)</intervention_name>
    <description>Comparison of different pacing modes available on the Cylos pacemaker device. In this intervention group, subjects were programmed to the Closed Loop Stimulation (DDD-CLS or VVI-CLS) pacing mode for the long-term follow-up portion of this study.</description>
    <arm_group_label>Closed Loop Stimulation (CLS)</arm_group_label>
    <other_name>Cylos Pacemaker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Rate Adaptive (R) Technology</intervention_name>
    <description>Comparison of different pacing modes available on the Cylos pacemaker device. In this intervention group, subjects were programmed to the standard are adaptive pacing mode (DDDR or VVIR) for the long-term follow-up portion of this study.</description>
    <arm_group_label>Standard Rate Adaptive Technology (R)</arm_group_label>
    <other_name>Cylos pacemaker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-rate adaptive (DDD) pacing</intervention_name>
    <description>Comparison of different pacing modes available on the Cylos pacemaker device. In this intervention group, subjects were programmed to the non-rate adaptive pacing mode (DDD or VVI) for the long-term follow-up portion of this study.</description>
    <arm_group_label>Non-rate adaptive pacing (DDD)</arm_group_label>
    <other_name>Cylos pacemaker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implanted within the last 45 days or being considered for implant with a BIOTRONIK
             pacemaker utilizing CLS rate adaptation technology (currently the Cylos family of
             pacemakers).

          -  Ability to give written informed consent

          -  Geographically stable and able to return for regular follow-ups for 12 months after
             ADL testing

          -  At least 18 years old

        Exclusion Criteria:

          -  Patients physically limited and unable to perform all or parts of the ADL testing

          -  Currently enrolled in any other clinical study

          -  Patients with medical reasons that preclude regular participation in the follow-ups
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Freddy Abi-Samra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ochsner Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Raymond Fernandez</name>
      <address>
        <city>Albertville</city>
        <state>Alabama</state>
        <zip>35951</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates-Gadsden</name>
      <address>
        <city>Gadsden</city>
        <state>Alabama</state>
        <zip>35901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Alabama Cardiology Center</name>
      <address>
        <city>Gadsden</city>
        <state>Alabama</state>
        <zip>35901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richard Kim, MD</name>
      <address>
        <city>Jasper</city>
        <state>Alabama</state>
        <zip>35501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Heart Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>N.R. Devaraj, M.D., Inc.</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Doctor Medical Group</name>
      <address>
        <city>Benicia</city>
        <state>California</state>
        <zip>94510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caremore Medical Group</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multani Medical Group</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Solano Cardiology</name>
      <address>
        <city>Fairfield</city>
        <state>California</state>
        <zip>94533</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Cardiology Associates</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Joaquin General Hospital</name>
      <address>
        <city>French Camp</city>
        <state>California</state>
        <zip>95231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kenny Charn, MD</name>
      <address>
        <city>Jackson</city>
        <state>California</state>
        <zip>95642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kartik Thaker, MD</name>
      <address>
        <city>Lakewood</city>
        <state>California</state>
        <zip>90712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Internal Medical Group</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio-Pulmonary Associates</name>
      <address>
        <city>Monterey</city>
        <state>California</state>
        <zip>93940</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke Cardiovascular Medical Group</name>
      <address>
        <city>Murrieta</city>
        <state>California</state>
        <zip>92562</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacramento Heart &amp; Vascular</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emad Khaleeli, MD</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torrance Memorial Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants</name>
      <address>
        <city>Turlock</city>
        <state>California</state>
        <zip>95382</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ventura Cardiology</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alireza Jafari, MD</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Cardiovascular Center</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boulder Medical Center</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Cardiology Associates</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Denver Cardiology Associates</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Cardiology Associates</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfieri Cardiology</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Heart Group</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Melbourne Internal Medicine Associates</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complete Cardiology Care</name>
      <address>
        <city>New Smyrna Beach</city>
        <state>Florida</state>
        <zip>32168</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants, PA</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Space Coast Cardiology Consultants</name>
      <address>
        <city>Port St. John</city>
        <state>Florida</state>
        <zip>32927</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brevard Cardiovascular Research Association</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <zip>32955</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northside Cardiology, PC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doris Tummillo, MD</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Collins Cardiology</name>
      <address>
        <city>Douglas</city>
        <state>Georgia</state>
        <zip>31533</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Douglas Medical Specialists</name>
      <address>
        <city>Douglas</city>
        <state>Georgia</state>
        <zip>31533</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Cardiology Consultants - Alton</name>
      <address>
        <city>Alton</city>
        <state>Illinois</state>
        <zip>62002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naeem Khan, MD</name>
      <address>
        <city>Centralia</city>
        <state>Illinois</state>
        <zip>62801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amr El-Shafei, MD</name>
      <address>
        <city>Mount Vernon</city>
        <state>Illinois</state>
        <zip>62864</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bluegrass Cardiology</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New England Cardiovascular Specialists</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Michigan Cardiology</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49525</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thorasic and Cardiovascular Institute</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis VA</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pidikiti Cardiology</name>
      <address>
        <city>Corinth</city>
        <state>Mississippi</state>
        <zip>38834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coast Heart Institute</name>
      <address>
        <city>Gulfport</city>
        <state>Mississippi</state>
        <zip>39501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Health Professionals, P.C.</name>
      <address>
        <city>Bridgeton</city>
        <state>Missouri</state>
        <zip>63044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Specialists of St. Lukes</name>
      <address>
        <city>Crystal City</city>
        <state>Missouri</state>
        <zip>63019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chand Medical Office</name>
      <address>
        <city>Farmington</city>
        <state>Missouri</state>
        <zip>63640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manzoor Tariq, MD</name>
      <address>
        <city>Festus</city>
        <state>Missouri</state>
        <zip>63028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liberty Cardiovascular Specialists</name>
      <address>
        <city>Liberty</city>
        <state>Missouri</state>
        <zip>64068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Medical Associates, LLC</name>
      <address>
        <city>Moberly</city>
        <state>Missouri</state>
        <zip>65270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lake Cardiovascular Institute, P.C.</name>
      <address>
        <city>Osage Beach</city>
        <state>Missouri</state>
        <zip>65065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zia Ahmad, MD, FACC</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gateway Cardiology, PC</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Cardiology Center, P.C.</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Cardiovascular Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lalit Chouhan, MD</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Heart and Vascular, P.C.</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbas Shehadeh, MD, FACC</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>White Sands Institute for Clinical Research</name>
      <address>
        <city>Las Cruces</city>
        <state>New Mexico</state>
        <zip>88011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohri Medical Group, P.C.</name>
      <address>
        <city>Warsaw</city>
        <state>New York</state>
        <zip>14569</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Group of the Carolinas</name>
      <address>
        <city>Concord</city>
        <state>North Carolina</state>
        <zip>28025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart Care</name>
      <address>
        <city>Elkin</city>
        <state>North Carolina</state>
        <zip>28621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart Specialists</name>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <zip>28054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Cardiology</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westside Cardiology Associates, Inc.</name>
      <address>
        <city>Fairview Park</city>
        <state>Ohio</state>
        <zip>44126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic Cardiology</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryan Lucenta, MD</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakshmi Mizin, M.D.</name>
      <address>
        <city>Carbondale</city>
        <state>Pennsylvania</state>
        <zip>18407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alderfer &amp; Travis Associates</name>
      <address>
        <city>Sellersville</city>
        <state>Pennsylvania</state>
        <zip>18960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart and Vascular Center</name>
      <address>
        <city>Aiken</city>
        <state>South Carolina</state>
        <zip>29801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Cardiology</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Carolina Heart Center</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pee Dee Cardiology</name>
      <address>
        <city>Florence</city>
        <state>South Carolina</state>
        <zip>29505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart Specialists</name>
      <address>
        <city>Lancaster</city>
        <state>South Carolina</state>
        <zip>29720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Cardiology Associates</name>
      <address>
        <city>Rock Hill</city>
        <state>South Carolina</state>
        <zip>29732</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Rhythm Specialists of East Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37923</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lone Star Arrhythmia and Heart Failure Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Cardiac Clinic</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Worth Heart</name>
      <address>
        <city>Burleson</city>
        <state>Texas</state>
        <zip>76028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Care Consultants</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Worth Heart</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of West Texas</name>
      <address>
        <city>San Angelo</city>
        <state>Texas</state>
        <zip>76904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Electrophysiology Consultants of S. Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wasatch Cardiology Consultants, PC</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of Virginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daniel Gottlieb</name>
      <address>
        <city>Burien</city>
        <state>Washington</state>
        <zip>98166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waukesha Heart Institute</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2006</study_first_submitted>
  <study_first_submitted_qc>July 24, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2006</study_first_posted>
  <results_first_submitted>June 6, 2011</results_first_submitted>
  <results_first_submitted_qc>June 6, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 27, 2011</results_first_posted>
  <last_update_submitted>December 18, 2012</last_update_submitted>
  <last_update_submitted_qc>December 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bradycardia</keyword>
  <keyword>Sinus Node Dysfunction</keyword>
  <keyword>Chronotropic incompetence</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>Rate adaptive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CLS Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
        </group>
        <group group_id="P2">
          <title>Standard Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
        </group>
        <group group_id="P3">
          <title>No Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="741"/>
                <participants group_id="P2" count="369"/>
                <participants group_id="P3" count="381"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="501"/>
                <participants group_id="P2" count="221"/>
                <participants group_id="P3" count="239"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="240"/>
                <participants group_id="P2" count="148"/>
                <participants group_id="P3" count="142"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CLS Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
        </group>
        <group group_id="B2">
          <title>Standard Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
        </group>
        <group group_id="B3">
          <title>No Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="741"/>
            <count group_id="B2" value="369"/>
            <count group_id="B3" value="381"/>
            <count group_id="B4" value="1491"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.5" spread="11.7"/>
                    <measurement group_id="B2" value="72.5" spread="12.0"/>
                    <measurement group_id="B3" value="72.7" spread="12.4"/>
                    <measurement group_id="B4" value="73.1" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="308"/>
                    <measurement group_id="B2" value="178"/>
                    <measurement group_id="B3" value="190"/>
                    <measurement group_id="B4" value="676"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="433"/>
                    <measurement group_id="B2" value="191"/>
                    <measurement group_id="B3" value="191"/>
                    <measurement group_id="B4" value="815"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Performance of Activities of Daily Living Tests (6-minute Walk and Sweep)</title>
        <description>Six-minute walk test and sweep test results for subjects completing tests in all three pacing modes and requiring at least 80% pacing during both tests in the CLS and R pacing modes. The mean composite of repetitions (six minute walk plus sweep) are presented.</description>
        <time_frame>within 45 days of enrollment</time_frame>
        <population>Patients requiring at least 80% pacing during both tests in the CLS and accelerometer pacing modes are included.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Performance of Activities of Daily Living Tests (6-minute Walk and Sweep)</title>
          <description>Six-minute walk test and sweep test results for subjects completing tests in all three pacing modes and requiring at least 80% pacing during both tests in the CLS and R pacing modes. The mean composite of repetitions (six minute walk plus sweep) are presented.</description>
          <population>Patients requiring at least 80% pacing during both tests in the CLS and accelerometer pacing modes are included.</population>
          <units>repetitions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.28" spread="9.70"/>
                    <measurement group_id="O2" value="18.09" spread="9.36"/>
                    <measurement group_id="O3" value="18.05" spread="9.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The endpoint will compare the composite percent change in ADL performance for patients while their devices are programmed to CLS and accelerometer pacing modes, using the no rate adaptive pacing mode as the baseline. Null hypothesis: mean composite of percent change for patients with their device programmed to CLS is less than or equal to the mean composite of percent change for the same patients with their device in accelerometer.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>9.17</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>15.90</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.24</ci_lower_limit>
            <ci_upper_limit>15.11</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Quality of Life</title>
        <description>Change in Quality of life (QOL) score was determined from baseline to the 12 month follow-up visit. The QOL utilized the physical functioning scale of the SF-36 v2, in which a higher score indicates a better health perception. Best possible score was 57.03 while the worst possible score was 14.94.</description>
        <time_frame>baseline and 12 months</time_frame>
        <population>Subjects completing a QOL at both baseline and 12 month follow-up were included in an intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Life</title>
          <description>Change in Quality of life (QOL) score was determined from baseline to the 12 month follow-up visit. The QOL utilized the physical functioning scale of the SF-36 v2, in which a higher score indicates a better health perception. Best possible score was 57.03 while the worst possible score was 14.94.</description>
          <population>Subjects completing a QOL at both baseline and 12 month follow-up were included in an intention to treat analysis.</population>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="464"/>
                <count group_id="O2" value="208"/>
                <count group_id="O3" value="221"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.41" spread="10.38"/>
                    <measurement group_id="O2" value="0.37" spread="10.38"/>
                    <measurement group_id="O3" value="-0.41" spread="9.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mode Reprogramming</title>
        <description>Number of subjects with device reprogramming from dual (atrial and ventricular pacing) to single chamber (ventricular pacing only) or from single (ventricular pacing only) to dual chamber (atrial and ventricular pacing) during the 12 month follow-up.</description>
        <time_frame>12 months</time_frame>
        <population>Subjects completing at least one follow-up visit were analyzed using intention to treat.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Mode Reprogramming</title>
          <description>Number of subjects with device reprogramming from dual (atrial and ventricular pacing) to single chamber (ventricular pacing only) or from single (ventricular pacing only) to dual chamber (atrial and ventricular pacing) during the 12 month follow-up.</description>
          <population>Subjects completing at least one follow-up visit were analyzed using intention to treat.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="499"/>
                <count group_id="O2" value="221"/>
                <count group_id="O3" value="238"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dual to single chamber</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Single to dual chamber</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Atrial Fibrillation (AF) Burden</title>
        <description>AF burden was measured at 12 months as the percentage of total atrial beats that are at or above 160 bpm.</description>
        <time_frame>12 months</time_frame>
        <population>Percentage of atrial burden was collected for subjects utilizing dual chamber pacing that completing a 12-month follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Atrial Fibrillation (AF) Burden</title>
          <description>AF burden was measured at 12 months as the percentage of total atrial beats that are at or above 160 bpm.</description>
          <population>Percentage of atrial burden was collected for subjects utilizing dual chamber pacing that completing a 12-month follow-up visit.</population>
          <units>percentage of atrial beats</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="409"/>
                <count group_id="O2" value="183"/>
                <count group_id="O3" value="212"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.54" spread="20.75"/>
                    <measurement group_id="O2" value="5.57" spread="16.81"/>
                    <measurement group_id="O3" value="6.65" spread="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Symptoms</title>
        <description>Number of subjects exhibiting each cardiac symptom was determined at the 12 month follow-up visit.</description>
        <time_frame>12 months</time_frame>
        <population>All subjects answering questions about current cardiac symptoms at the 12-month visit were included in this intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Symptoms</title>
          <description>Number of subjects exhibiting each cardiac symptom was determined at the 12 month follow-up visit.</description>
          <population>All subjects answering questions about current cardiac symptoms at the 12-month visit were included in this intention to treat analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="471"/>
                <count group_id="O2" value="209"/>
                <count group_id="O3" value="230"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizzy Spells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chest Pains</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Weakness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Palpitations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypotension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Shortness of Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in New York Heart Association (NYHA) Class</title>
        <description>Number of subjects with improved, no change, or worsened NYHA classification at the 12-month visit, as compared to baseline. NYHA classifications (I to IV) are used to assess the various stages of heart failure, with Class I relating to mild heart failure and Class IV relating to severe heart failure.</description>
        <time_frame>baseline and 12 months</time_frame>
        <population>Subjects with NYHA classifications at both enrollment and at the 12-month visit were analyzed using intention to treat.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in New York Heart Association (NYHA) Class</title>
          <description>Number of subjects with improved, no change, or worsened NYHA classification at the 12-month visit, as compared to baseline. NYHA classifications (I to IV) are used to assess the various stages of heart failure, with Class I relating to mild heart failure and Class IV relating to severe heart failure.</description>
          <population>Subjects with NYHA classifications at both enrollment and at the 12-month visit were analyzed using intention to treat.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="470"/>
                <count group_id="O2" value="201"/>
                <count group_id="O3" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Improved 2 classes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Improved 1 class</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="341"/>
                    <measurement group_id="O2" value="143"/>
                    <measurement group_id="O3" value="166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsened 1 class</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsened 2 classes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in 6-minute Walk Test Distance</title>
        <description>Change in number of 10 foot repetitions between baseline and 12-month visit were examined.</description>
        <time_frame>baseline and 12 months</time_frame>
        <population>Subjects completing the 6 minute walk at both enrollment and at the 12-month visit were included in intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 6-minute Walk Test Distance</title>
          <description>Change in number of 10 foot repetitions between baseline and 12-month visit were examined.</description>
          <population>Subjects completing the 6 minute walk at both enrollment and at the 12-month visit were included in intention to treat analysis.</population>
          <units>repetitions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="436"/>
                <count group_id="O2" value="197"/>
                <count group_id="O3" value="203"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="3.63"/>
                    <measurement group_id="O2" value="0.41" spread="3.36"/>
                    <measurement group_id="O3" value="0.27" spread="3.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pulse Pressure During Activities of Daily Living Tests (Orthostatic Test)</title>
        <description>Patients completing the orthostatic test in all three pacing modes and that had at least 80% pacing during the test in the CLS and R pacing modes are included in the analysis. The mean pulse pressure is provided.</description>
        <time_frame>within 45 days of enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CLS Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Standard Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
          </group>
          <group group_id="O3">
            <title>No Rate Adaptive Pacing</title>
            <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Pulse Pressure During Activities of Daily Living Tests (Orthostatic Test)</title>
          <description>Patients completing the orthostatic test in all three pacing modes and that had at least 80% pacing during the test in the CLS and R pacing modes are included in the analysis. The mean pulse pressure is provided.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.13" spread="12.35"/>
                    <measurement group_id="O2" value="50.00" spread="14.4"/>
                    <measurement group_id="O3" value="50.54" spread="15.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The purpose of endpoint was to evaluate the percent change in pulse pressure during test. The null hypothesis was the mean percent change for patients with their device programmed to CLS is greater or equal to the mean percent change for the same patients with their device in accelerometer.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.552</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-1.42</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>17.74</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.17</ci_lower_limit>
            <ci_upper_limit>3.33</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The purpose of endpoint was to evaluate the percent change in pulse pressure during test. The null hypothesis was the mean percent change for patients with their device programmed to CLS is greater or equal to the mean percent change for the same patients with their device without rate adaptative pacing.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.505</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>1.91</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>21.34</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.80</ci_lower_limit>
            <ci_upper_limit>7.63</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CLS Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with Closed Loop Stimulation (CLS) rate adaptive technology for long-term study follow-up.</description>
        </group>
        <group group_id="E2">
          <title>Standard Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with standard rate adaptive technology (R, accelerometer) for long-term study follow-up.</description>
        </group>
        <group group_id="E3">
          <title>No Rate Adaptive Pacing</title>
          <description>Pacemaker programmed with no rate adaption (DDD) for long-term study follow-up.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="741"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="381"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="741"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="369"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="381"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac symptoms with Catheterization</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="741"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="369"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Lead revision</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="741"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Device explants (for any reason)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="741"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Symptomatic arrhythmia requiring ablation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="741"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Change in status requiring device upgrade</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="741"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Mitral valve replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="741"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Pacemaker pocket revision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="741"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Pacemaker change-out (not device related)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="741"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="381"/>
              </event>
              <event>
                <sub_title>Other cardiac procedure not captured in other groups</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="741"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="381"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac procedure performed</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="741"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="381"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>CLEAR Study CSE</name_or_title>
      <organization>BIOTRONIK, Inc.</organization>
      <phone>503-451-8051</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

